Effect of bisphosphonate use on risk of postmenopausal breast cancer: results from the randomized clinical trials of alendronate and zoledronic acid.
about
Prevention and treatment of bone fragility in cancer patientManaging Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral ResearchThe carcinogenicity of alendronate in patients with osteoporosis: evidence from cohort studiesOral bisphosphonate use and risk of postmenopausal endometrial cancer.Modelling circulating tumour cells for personalised survival prediction in metastatic breast cancerAnalysis of Immune Cells from Human Mammary Ductal Epithelial Organoids Reveals Vδ2+ T Cells That Efficiently Target Breast Carcinoma Cells in the Presence of BisphosphonateRisks and Benefits of Bisphosphonate Therapies.Bone microenvironment-mediated resistance of cancer cells to bisphosphonates and impact on bone osteocytes/stem cells.Subtrochanteric femoral stress fracture with features of atypical femoral fracture in patient with Paget's disease: a case report.Bisphosphonate conjugation for bone specific drug targeting.
P2860
Q26775765-90C34679-F530-4334-B049-621991F65485Q26782621-2274DB6E-9AFD-47BA-A365-C179393AF367Q28087279-71B9CE70-07BC-497C-960C-F26861476E9EQ35215054-915DBBDD-FAD1-4C43-AD21-B4B66D852FBDQ35610546-CEF3FEF0-B4E6-401F-A3A6-08D255805909Q36759195-4C5F244C-6749-4BE2-9488-8D66B2BA8D75Q38533828-7A33C3C7-F844-4CD8-8E0F-3850FC97BBC6Q46277856-43554C07-FF4A-4615-993A-1F1C4AECCB97Q49465302-92378CBF-8FBE-4EF8-A232-686E58DF22B0Q55515922-E25F8DAB-9B72-4532-97A1-811822BA39AD
P2860
Effect of bisphosphonate use on risk of postmenopausal breast cancer: results from the randomized clinical trials of alendronate and zoledronic acid.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Effect of bisphosphonate use o ...... endronate and zoledronic acid.
@ast
Effect of bisphosphonate use o ...... endronate and zoledronic acid.
@en
type
label
Effect of bisphosphonate use o ...... endronate and zoledronic acid.
@ast
Effect of bisphosphonate use o ...... endronate and zoledronic acid.
@en
prefLabel
Effect of bisphosphonate use o ...... endronate and zoledronic acid.
@ast
Effect of bisphosphonate use o ...... endronate and zoledronic acid.
@en
P2093
P2860
P1476
Effect of bisphosphonate use o ...... endronate and zoledronic acid.
@en
P2093
Dennis M Black
Douglas C Bauer
Kristine E Ensrud
Steven R Cummings
Trisha F Hue
P2860
P304
P356
10.1001/JAMAINTERNMED.2014.3634
P577
2014-10-01T00:00:00Z